2021
DOI: 10.3389/fimmu.2021.631291
|View full text |Cite
|
Sign up to set email alerts
|

Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis

Abstract: Mesenchymal stem cell (MSC) therapies have been used as cell-based treatments for decades, owing to their anti-inflammatory, immunomodulatory, and regenerative properties. With high expectations, many ongoing clinical trials are investigating the safety and efficacy of MSC therapies to treat arthritic diseases. Studies on osteoarthritis (OA) have shown positive clinical outcomes, with improved joint function, pain level, and quality of life. In addition, few clinical MSC trials conducted on rheumatoid arthriti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
61
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 95 publications
(80 citation statements)
references
References 141 publications
(198 reference statements)
1
61
0
2
Order By: Relevance
“…Synovial-MSCs (S-MSCs) isolated and characterized first in 2001, are also promising tools for the treatment OA due to their natural homing in this site [70]. They were shown to have high chondrogenic differentiation capacities, high expression of type II collagen, compared to other sources of MSCs [71,72].…”
Section: Adipocyte Derived Stem Cell Role In Regenerate Knee Osteoarthritismentioning
confidence: 99%
See 2 more Smart Citations
“…Synovial-MSCs (S-MSCs) isolated and characterized first in 2001, are also promising tools for the treatment OA due to their natural homing in this site [70]. They were shown to have high chondrogenic differentiation capacities, high expression of type II collagen, compared to other sources of MSCs [71,72].…”
Section: Adipocyte Derived Stem Cell Role In Regenerate Knee Osteoarthritismentioning
confidence: 99%
“…So far, there have been few approved clinical application for the MSCs in different countries. Few examples, are the application of allogeneic MSCs for the treatment of graft versus host disease (GVHD) in Japan, autologous bone marrow MSCs for amyotrophic lateral sclerosis and autologous adipose MSCs for Chron's fistula, human umbilical cord blood-derived MSCs for osteoarthritis in South Korea, and in Europe the application of allogenic adipose MSCs for the treatment of fistulas in Crohn's disease [70].…”
Section: Clinical Trials With Ascsmentioning
confidence: 99%
See 1 more Smart Citation
“…Significant numbers of other clinical trials are dealing with the use of MSCs' immunomodulatory properties as standalone therapy for various diseases and conditions associated with overactivated immune systems. MSCs were tested for treatment of rheumatoid arthritis and osteoarthritis [225], multiple sclerosis [226], inflammatory bowel disease [227], systemic lupus erythematosus [228], diabetes mellitus [229], among other pathologies. In most reported cases, good safety profiles and encouraging outcomes were reported.…”
Section: Translation To the Clinicmentioning
confidence: 99%
“…Both OA and RA do not yet have an ideal therapy that can fully cure the disease [ 12 ]. In the case of RA, the overall goal is to relieve pain and decrease inflammation [ 13 ].…”
Section: Ac and Arthritic Diseasesmentioning
confidence: 99%